These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 3115654

  • 1. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
    Ng YC, Peters DK, Cederholm-Williams SA, Walport MJ.
    Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
    [Abstract] [Full Text] [Related]

  • 2. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 3. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH, Liu HW, Lin SF, Chen JR, Chen TP.
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [Abstract] [Full Text] [Related]

  • 4. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA, Ng YC, Paccaud JP, Walport MJ.
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [Abstract] [Full Text] [Related]

  • 5. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG.
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [Abstract] [Full Text] [Related]

  • 6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 7. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M.
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [Abstract] [Full Text] [Related]

  • 8. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M, Schifferli JA.
    Schweiz Med Wochenschr; 1993 Jan 23; 123(3):39-43. PubMed ID: 8426946
    [Abstract] [Full Text] [Related]

  • 9. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC, Wright E, Taylor RP.
    J Immunol; 1987 Dec 01; 139(11):3739-47. PubMed ID: 2960742
    [Abstract] [Full Text] [Related]

  • 10. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP, Carpentier JL, Schifferli JA.
    Eur J Immunol; 1990 Feb 01; 20(2):283-9. PubMed ID: 2138082
    [Abstract] [Full Text] [Related]

  • 11. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC, Schifferli JA, Walport MJ.
    Clin Exp Immunol; 1988 Mar 01; 71(3):481-5. PubMed ID: 2968204
    [Abstract] [Full Text] [Related]

  • 12. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N.
    Mol Immunol; 2004 Jun 01; 41(4):449-56. PubMed ID: 15163541
    [Abstract] [Full Text] [Related]

  • 13. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W, Burdick G, Carl V, Lachmann PJ.
    J Immunol; 1989 Jun 15; 142(12):4366-71. PubMed ID: 2524529
    [Abstract] [Full Text] [Related]

  • 14. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
    Mitchell JA, Batchelor JR, Chapel H, Spiers CN, Sim E.
    Clin Exp Immunol; 1987 May 15; 68(2):446-56. PubMed ID: 2958187
    [Abstract] [Full Text] [Related]

  • 15. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML, Bankovich AJ, McElhenny JL, Taylor RP.
    Arthritis Rheum; 2000 Oct 15; 43(10):2265-75. PubMed ID: 11037886
    [Abstract] [Full Text] [Related]

  • 16. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC, Kimberly RP, Taylor RP.
    Eur J Immunol; 1992 Jun 15; 22(6):1333-9. PubMed ID: 1376254
    [Abstract] [Full Text] [Related]

  • 17. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME, Oger JJ, Antel JP, Prince GM.
    J Clin Lab Immunol; 1982 Feb 15; 7(2):93-103. PubMed ID: 7069786
    [Abstract] [Full Text] [Related]

  • 18. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB, Sarano J, Manni JA, Casellas AM.
    Medicina (B Aires); 1990 Feb 15; 50(1):21-4. PubMed ID: 2149869
    [Abstract] [Full Text] [Related]

  • 19. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
    Beynon HL, Davies KA, Haskard DO, Walport MJ.
    J Immunol; 1994 Oct 01; 153(7):3160-7. PubMed ID: 8089493
    [Abstract] [Full Text] [Related]

  • 20. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
    Walport M, Ng YC, Lachmann PJ.
    Clin Exp Immunol; 1987 Sep 01; 69(3):501-7. PubMed ID: 2959411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.